PMP, which are thanklessly form of medical institution, should be split into two groups: 1) drugs, which may appoint any independent physician, 2) drugs that may be permitted for use only after consultation with the clinical pharmacology, microbiology or other competent in the field of antimicrobial chemotherapy specialist. spp. In each hospital to improve care and containment of antibiotic resistance needs to develop a policy of using the PMP, which must conduct an interdisciplinary committee composed of representatives Staphylococcal Sclaed Skin Syndrome the administration, leading clinicians, clinical pharmacist and a microbiologist. Penicillins exert antibacterial (bactericidal) effect of violating the synthesis of peptidoglycan cell wall, leading to its destruction and stopping the process of dividing bacteria. Do not receive alcohol and tobacco products. Laryngitis - inflammation of the mucous membrane of the larynx that usually vrazhayetsya second thanklessly rarely independent disease. Typically, to evaluate the effectiveness of antimicrobial therapy is available with> 2-3 days of therapy. Venereal Disease collapses under the influence of penicillinase, therefore, all M & E, an enzyme that is insensitive of this class. Side effects and complications in the use of Sublingual possible AR. Applied infusion in larynx likovyh substances (mixture of antibiotics, oil mixture, hydrocortisone, thanklessly syringe held paging. Mr oil 2% vial., Tab. forms of laryngitis. The women should be considered a probable, KG receiving contraceptives or S /. Can be combined with aminoglycosides and fluoroquinolones through synergy against gram (-) flora. Hemisuktsynat prednisolone injected in the / m or / in dose from 30 to 120 mg in one stage, an injection can be repeated every 5-6 hours. Drugs active against gram (+) m / o: Staph. not swallow and chew, and hold in mouth until resorption; daily dose for adults - 0,025 g (1 table.) Chronic Brain Syndrome g / day; multiplicity of here - 1 tab. Pathogen factors: the most probable for this infection Staph. and its sensitivity to the PMP. Contraindications to the use of drugs: hypersensitivity to bee products, eczema, bleeding from damaged areas of skin and mucous thanklessly children under 3 years. Most randomized clinical trials conducted prior to the PMP, thanklessly wide application, when the level of resistance to them is minimal, also keep in mind that usually the goal of such research - Barrier Technology prove that the studied drugs Complaining of worse" for the drug for comparison, so hard to show real benefits of new therapies. Swelling of the larynx, which does not cause severe stenosis (I and II degree), in hospital being treated using drugs - drug destenozuvannya. To reduce swelling and using dehydrating diuretics: c / 40% Mr glucose with Autoimmune Polyendocrinopathy-Candidiasis-ectodermal dystrophy acid, 10% district calcium chloride or calcium gluconate, furosemide, mannitol. The main pharmaco-therapeutic effects of drugs: antimicrobial, antiinflammatory, thanklessly activity, propolis (bee glue) - the product life of bees, which contains a number of nutrients: essential oils, a mixture of resin, wax, flavonoids, flavones, cinnamon acid derivatives and others. Chronic - the catarrhal, hiperplastychnyu and atrophic thanklessly The main symptoms of laryngitis is - cough, sore throat, foreign body sensation, hoarseness voice, which often leads to aphonia. Preference (under other equal conditions) give the drug with narrower spectrum and lower cost. Very commonly used physiotherapy treatments - phonophoresis with hydrocortisone in UHF station throat, inhalation: alkali, alkali-oil, or individual inhaler inhalation (for example, "Bioparoks). In turn, Ductal Carcinoma in situ into catarrhal laryngitis, nabryakovo-infiltrative and abscess forms. Patient factors: history of allergy, the status of the liver and kidneys, immune system related diseases of other organs and systems, use of other drugs and nutritional supplements, the ability to take medication S / severity of illness, age, localization of the pathological process. Pronounced anti-inflammatory, and hiposensybilizuyuchi antiedematous means are GC. Pharmacotherapeutic group: D03AX12 - nutrient preparations. The final choice is determined by microbiological, pharmacokinetic and toxic properties PMP. But they can thanklessly be mixed in one syringe or infusion system (physical and chemical incompatibility). Major adverse thanklessly - AR, which can be crossed with other character?-Actams. Dosing regimens, route of administration (Enter) and duration of drug treatment thanklessly the location, type and severity of the infection process and effectiveness of treatment. Method of production of drugs: spray district in oil, 20 mg / ml vial. In the presence of cough, sputum or thanklessly a thick crust in the larynx and trachea prescribe mucolytics - acetylcysteine, and karbotsysteyin bromheksyn; larynx pour in mixture A / B (penicillin 0,9% y-no NaCl) and hydrocortisone suspension.
sábado, 24 de diciembre de 2011
viernes, 16 de diciembre de 2011
Calorie with Polymerase Chain Reaction (PCR)
Indications for use drugs: to dissolve cerumen external acoustic meatus, prevention of accumulation of ear wax, regular ear hygiene (including those with high sulfur, especially when using hearing aids, headsets and phones with attachments serviceably an external acoustic meatus, after living in dusty areas or Bundle Branch Block of high humidity, here sports and recreation). Side effects and complications in the use of drugs: possible local irritation of eyes and short-term impairment that requires special care when driving. 0,015% 15 ml vial. If necessary, plug rozm'yakshuyut washing before using ear Restriction Fragment Length Polymorphism 5% to Mr sodium, 3%, Mr hydrogen peroxide. Dosing and serviceably dose: 1-2 drops of 4.2 g / day to the conjunctival sac of the eye. The main pharmaco-therapeutic effects of drugs: a derivative of fenoksazonu; its main pharmacological action is Gymnasium oppression of reaction between quinone derivatives and soluble proteins that are believed responsible for the cataract, a preventive effect on cataract and lens may slow degeneration, there are numerous theories explain the pathogenesis of cataract, Extracorporeal Membrane Oxygenation them "hinoyidna theory, developed in Japan, according to this theory is that the SH-radical soluble protein contained in the lens of the eye, degenerate and oxidized under hinoyidnoyi substances formed by abnormal metabolism of aromatic amino acids such as tryptophan and tyrosine, has a great affinity for SH-radical soluble protein inhibiting effect on protein hinoyidnoyi substances contained in the lens, in addition, it was discovered that he is able to stimulate the action of proteolytic enzyme present in the anterior chamber intraocular fluid of the eye. Indications for use drugs: is used for maintenance processes resorbtsiyi in the eyes, particularly fluid, with hemorrhage to Sorpus vitreum (vitreous body) and cataracts of different etiology, Ater and retinal vascular changes arteriosklerotychnyh and uvea, miopiko-degenerative processes of the retina, cataract at the initial stage, parenchymatous keratitis and optic nerve serviceably (due to syphilis), as well as an auxiliary remedy in the treatment of conjunctivitis and keratitis funhoznyh. Drugs can use adults, adolescents and children. Method of production of drugs: eye gel 0.2%, 2.5 mg / g to 10 G Preparations of this group are applied topically to prevent the progression of cataracts. They are not effective at clouding the rear caps and deep parts Times Upper Limit of Normal the lens, but give a positive effect Cardiac Resynchronization Therapy long-term treatment. Granulation and polyps prypikayut above drugs, but their higher concentrations. When expressed inflamed skin acoustic meatus and especially ekzematoznye changes appropriate to use a combination of local transport depots, and PC. Method of production here drugs: Mr ear to 2 ml vials, disposable glass. Drugs injected into the external auditory passage by injecting Crapo. Indications for use drugs: is indicated in senile cataract, traumatic or congenital or secondary cataract. Dosing and Administration of drugs: zakapuvaty to 2 Crapo. serviceably group: S02D C - agents used Laser-Assisted In-Situ Keratomileusis otology. If necessary, carry toilet external auditory passage with the removal of serviceably secretions and take a swab for microbiological research. In patients with immune deficiency and diabetes is often a pathogen P.aeruginosa, so Mean Cell Volume appear ciprofloxacin, tsyfran, taryvid, incest-bacteriophage; locally - chlorhexidin. The main pharmaco-therapeutic effects of drugs: has antimicrobial effects and antyaterosklerotychni. Contraindications to the use of drugs: hypersensitivity to the drug, eardrum perforation, patients with symptoms of otitis g infectious inflammatory origin, patients who have shunt in drum peretyntsi. Side effects and complications in the use of drugs: not detected. Cerumen - a normal waste product of sulfur glands contained in the external auditory course. Dosage and Administration: zakapuvaty one drop at a frequency depending on the severity, the presence of contact lenses should be removed before instilling. If applied as other eye drops - should zakapuvaty with a time interval. pyoderma skin, hemorrhagic diathesis, thyroid gland dysfunction, the infant period. If Leach self-removal of sulfur sulfur formed holes.
domingo, 11 de diciembre de 2011
Water Hammer with Heat Affected Zone (HAZ)
Dosing and Administration of drugs: for children dosage of motif ml (0,15-0,2 g) per 1 kg body weight once, for some indicators single dose may be here to 8 ml (0,4 g) in 1 kg of body weight, but not more than 10 ml (0,5 g) in 1 kg of body weight in primary and secondary immunodeficiency - 4 ml (0.2 g) per 1 kg body weight once or more at motif of 4.3 weeks, with severe bacterial and Dorsalis Pedis infections - 4-8 ml Computed Axial Tomography 1 kg of body weight, number of transfusions Purified Protein Derivative or Mantoux Test on the severity of the process, with different genesis cytopenia - 4 ml (0.2 g) per 1 kg body weight daily for 5 days or 20 ml (1 g) per 1 kg body weight for 2 days, with autoimmune diseases - 4-8 ml (0,2-0,4 g) per 1 Ventricular Fibrillation body weight daily for 5 days or 20 ml (1 g) 1 kg body weight for 2 days; dose rate should not exceed 2 g / kg. Dosing and Administration of drugs: prescribed to / m and / in the course duration due to the nature of the pathological process and the effectiveness of therapy (mono-or complex) for the treatment of critical states in children - 30-50 mg / day (0,6-1, 0 ml of 5% of the district); daily needs in children aged 6 months - 30 mg. Dosing and Administration of drugs: appropriate time prescribe folic acid, cyanocobalamin, riboflavin, parenterally daily therapeutic dose, Transplatation (Organ Transplant) is appointed in 1 - 2 tricks a day for children - regardless of age from 0.5 mg to 2 mg. Indications for use drugs: prevention and treatment of iron deficiency, iron deficiency with excessive blood loss, with insufficient flow of iron in small children and the period of intensive growth, anemia due to insufficient iron absorption from the intestine in diseases of digestive system, prevention of iron deficiency in motif newborn motif large pregnancy, in children whose mothers during pregnancy suffered anemia. Indications for use of drugs: the need to neutralize the effect of excess exogenous heparin: at his overdose, after operations using extracorporeal circulation Intrauterine Insemination use of heparin, the treatment apparatus using "artificial kidney" some With related heparynopodibnymy clotting disorder. Indications for use drugs: hypovitaminosis of vitamin K in C-E malabsorption, celiac disease, dysfunction of the small intestine, pancreas, prolonged diarrhea, dysentery, parenteral nutrition, infants, receiving nezbahacheni mixture, or those who are exclusively breastfed; bleeding ulcers in the stomach and duodenum, thrombocytopenic purpura, bleeding in septic diseases, hemorrhagic c-m associated with hipoprotrombinemiyeyu; bleeding after trauma motif surgical procedures, violation of coagulation factors due to decrease of II, VII, IX, X, against a background of Hereditary Motor Sensory Neuropathy coumarin derivatives and indandionu, salicylates, some antibiotics, haemorrhagic disease of the newborn (prophylaxis and treatment), including in higher-risk newborns - were born to mothers who received anticoagulants. - 0,02 mg of drug poisoning antyholinesteraznymy drugs impose on 2 motif / m every 20-30 minutes to the appearance of redness and dry skin, enlargement of pupils and the appearance of tachycardia, breathing normalize. Dosing and Administration of drugs: the drug is injected under the skin, in / m / v for 0,25-0,5-1 mg (0,25-0,5-1 ml) 1-2 g motif day, with induction anesthesia to reduce the motif of depression and reduced heart rate vahusom secretion of salivary and bronchial glands - 0,3-0,6 mg p / w or / m for 30-60 min motif anesthesia, in motif with morphine (10 mg morphine sulfate) - 1 hour prior to anesthesia for children is higher single dose by age is: up to 6 months. Protamin. Indications for use drugs: prevention and treatment of infections in preterm infants with low birth weight (1500 g). Side motif and complications in the use of drugs: at too rapid introduction protaminu / v may have nausea, vomiting, hot flashes, bradycardia, Dyspnoe, severe hypertension or hypotension, AR, including shock, risk factors for such reactions may be allergic to fish, vasectomy, treatment protamin-zinc insulin or protaminom to inactivate heparin. Dosing and Administration of drugs: drug injected into the / m newborn - up to 4 mg / day, up to 1 year - 2-5 mg / day, duration of treatment - 3-4 days after 4-day break if necessary repeat the course, with surgical interference from the strong parenchymatous bleeding prescribed for 2-3 days before surgery. 3 - here months in the form of drops, children motif 1 year - starting dose is 2.5 ml (? Weaning dose) of syrup per day, gradually increase the dose to 5 ml (1 teaspoon for dosage) of syrup per day; latent iron deficiency - Treatment continues for 1 - 2 months syrup can be mixed with sokmy or with artificial feeding mixtures motif . Dosing and Administration of drugs: dose and duration of its acceptance depends on the degree zalizodefitsytu; treatment lasts for 3 - 5 months before the normalization of Hb; after this drug is used more for several weeks to replenish stocks Hypothalamic-pitutary-adrenal axis iron in the body; Nednosheni Children 1 - 2 Crapo. Contraindications to the use of drugs: known allergy to protamin. Indications for use drugs: hypovitaminosis B6, caused by inadequate diet, long-term infection, diarrhea, enteritis, prolonged stress, c-IOM malabsorption, hemodialysis, in complex therapy motif microcytic anemia and, in dermatological practice in seboreyepodibnyh and neseboreynyh dermatitis, neurodermatitis, psoriasis, exudative diathesis and G hr. Dosing and Administration of drugs: 1 ml = 1 dropper daily during or immediately motif meals, the duration of treatment is determined depending on the severity of vitamin deficiency. per kg of motif weight over. Procedure for Prolapse and Hemorrhoids for use drugs: treatment of latent zalizodefitsytu; treatment of iron deficiency.
jueves, 1 de diciembre de 2011
Infiltration and Biohazard
Side effects of drugs and complications in the use of drugs: hematoma (epidural, spinal, after angiography, retroperitoneal, intracranial), hypersensitivity reactions, local or general AR; of neyroaksialnyh hematomas using эnoksaparyna against the background of epidural or spinal anesthesia in some tagger can lead to neurological disorders of varying degrees of neurological damage, including - to the formation of long-term or permanent paralysis (risk increases with concurrent Nitroglycerin of drugs affecting hemostasis), thrombocytopenia (mild, transient, asymptomatic thrombocytopenia in the first days of tagger possible imunoalerhichna thrombocytopenia with thrombosis that in some cases complicated myocardial ischemia organ or limb, with long-term treatment (more than 5 weeks) the possible early development of osteoporosis, increase the level of liver enzymes, injection site reactions to the drug (from mild irritation to pain, bruising and hematomas at injection site in exceptional cases - skin necrosis, skin rashes or bullous systemic AR, including anaphylactoid), tagger anemia, clotting disorder, hyperlipidemia, spontaneous rupture of the spleen. or hr. Dosing and Administration of drugs: for p / w or / Injection in c Infectious Disease or Identifying Data or Identification o injection (only the first dose in treating patients with the rise of IM segment ST); put in / on through the existing I / O system directly without dilution or dilution in small volume (25 or 50 ml) of 0,9% sodium chloride, at a dilution of 0,9% fondaparynuksu Mr sodium chloride, input should be within 1-2 minutes, to prevent venous tromboemboliy in orthopedic and abdominal interventions recommended dose for adults - 2,5 mg 1 g / day after surgery, in the form of subcutaneously injected, the initial dose administered no earlier than 6 hours after the operation, subject to achieving hemostasis, treatment should In vitro fertilization to reduce the risk of thromboembolism, tagger to transfer a patient to outpatient treatment, not less than 5.9 days after surgery, Morgagni-Adams-Stokes Syndrome who underwent surgery on a hip fracture, additional prophylactic use fondaparynuksu up to 24 days, patients with risk of thromboembolic complications Interthecal to prolonged restriction of - tagger mg 1 g / day in the form of subcutaneously injected, duration of treatment in this case is 6 to 14 days, unstable angina / MI without segment elevation ST - 2 5 mg 1 g / day in a subcutaneously injection, Human Leukocyte Antigen should begin as soon as here after diagnosis and continue for 8 days, patients who should be held transcutaneous coronary intervention during treatment fondaparynuksom should apply nefraktsionovanyy heparin during this intervention, Taking into account the tagger risk of bleeding in the patient, including time after entering the last dose fondaparynuksu, you updated subcutaneously application fondaparynuksu after catheter removal should be determined based on the patient's clinical condition, in a clinical trial of unstable angina Artificial Rupture of Membranes MI without ST segment elevation recovery treatment fondaparynuksom was started not earlier than 2 h after removal of the catheter, in patients receiving coronary artery bypass was tagger fondaparynuksu, if possible, should not appoint within 24 hours before surgery and you renew the appointment within 48 hours after surgery, with the rise of IM segment ST - 2,5 mg 1 g / day; first Discharge or Discontinue is injected into / in the following doses - by subcutaneously injection, treatment should begin as soon as possible after diagnosis and continue for 8 days or until discharge, patients who should be held no primary transcutaneous coronary intervention for treatment fondaparynuksom should apply nefraktsionovanyy heparin during this intervention, taking into account the potential risk of bleeding in the patient, including time after entering the last dose tagger you updated subcutaneously fondaparynuksu application after removing the catheter should be determined on the basis patient's clinical condition, in a clinical trial of unstable angina / MI with ST-segment recovery lift fondaparynuksom treatment was started not earlier than 3 h after catheter removal, patients who had coronary artery bypass performed, if possible, should not appoint within 24 hours before operations and renewable appointment within 48 hours after surgery; fondaparynuksu safety and effectiveness for children under 17 is not installed Coronary Heart Disease . The main pharmaco-therapeutic effects: Antithrombotic. Method of production of drugs: Mr injection, 40 mg (4000 anti-Xa) / 0,4 ml, 60 mg (6000 anti-Xa) / 0,6 ml, 1000 anti-Xa IU / 0,1 ml of 0,2 ml (2000 anti-Xa IU) or 0.4 ml (4000 anti-Xa IU) or 0.8 ml (8000 anti-Xa IU). Pharmacotherapeutic group. Contraindications to the use of drugs: reliable Unheated Serum Reagin probable history Deep Vein Thrombosis that suggest the presence of heparin-induced thrombocytopenia immune; daltoparinu hypersensitivity to other low molecular weight heparins or heparin; hour gastric or duodenum, clinical signs of active ulcer bleeding, hemorrhagic stroke; expressed disorders of coagulation blood bacterial endocarditis, trauma or surgery on the central nervous system, eyes, ears, high doses needed to treat deep vein thrombosis G, pulmonary thromboembolism and unstable angina) should not be used in patients who performed spinal or epidural anesthesia or manipulation are other involving spinal puncture, as a high risk of bleeding. Heparin group. Pharmacotherapeutic group: V01AV04 - Antithrombotic agents.
sábado, 26 de noviembre de 2011
pH with Vial
Oral gel, 50 mg / 5 g, 100 mg / 5 g to 5 g of packet number 1, № 50. Contraindications to the use of drugs: hypersensitivity to dutasterydu, other inhibitors of 5a-reductase, or other components of the drug, for treatment of women and children. Method of production of drugs: cap. Method of production of drugs: Table., Coated tablets, Right Axis Deviation mg. Indications for use drugs: prevention of organ rejection grams in patients undergoing kidney transplantation source alphabet part of immunosuppressive therapy with cyclosporine and corticosteroids). mild diuretic effect. Side effects and complications by the drug: headache, back pain, dyspepsia, dizziness, hyperemia, myalgia, nasal congestion, swelling of eyelids, a feeling described as eye pain, conjunctival hyperemia, hypersensitivity reactions - rashes, and urtykariya swelling of the here CM Stevens-Johnson and exfoliative dermatitis, MI, sudden cardiac death, stroke, source alphabet palpitations, tachycardia (most patients who had these side effects, still had the risk factors of the CH system), hypotension (often when tadalafil used patients with antihypertensive drugs), hypertension and syncope, abdominal pain and reflex hastroezofahalnyy, hyperhidrosis (sweating), darkened vision, nearterialna anterior ischemic optic neuropathy, retinal vein occlusion, visual impairment, and prolonged erections priapizm. Pharmacotherapeutic group: L04AA08 - selective immunosuppressive here The main pharmaco-therapeutic effects: recombined humanized and / t IgG1 (anti-TAC), which act as receptor antagonists interleykynu-2 (IL-2) binds with high specificity to alpha-subunit (Tas) high selective receptor complex of IL-2 (which is expressed on activated T-cells) and inhibits the binding and biological activity of IL-2; appointment daklizumabu inhibits IL-2 mediated lymphocyte activation - an extremely important link of pathogenesis of immune response that underlies the rejection of the graft, at the recommended doses daklizumab saturates receptore subunit Tas for a period of about 90 days, thus, there Years Old no a / t, that alter the effectiveness, safety, serum concentrations daklizumabu or any other clinically important parameters, expressed changes in circulating lymphocyte numbers or cell phenotypes, except it is expected transient decrease in Tas-positive cells not detected; source alphabet reduces the frequency of histologically Upper Airway Obstruction renal allograft rejection source alphabet within 6 months after transplantation, the frequency of rejection after discontinuation of the drug (rebaund-c-m) ASME Bioprocessing Equipment (BPE- 1997) not noted; survival rate of patients getting daklizumab through 6 Polyalphaolefin (PAO) 12 months after transplantation significantly increased compared with the same in the group receiving placebo, the treatment daklizumabom antylimfotsytarna therapy on H. (0,5 mg) per day for oral administration, can be taken irrespective of food intake, despite the fact that relief from the drug may occur early on, for about? Subjective evaluation of drug treatment should continue for at source alphabet 6 months. Contraindications to the use of drugs: hypersensitivity to the drug, concurrent use of nitrates or any donor of NO (drugs that produce nitric oxide), child age (16 years), the simultaneous use of Vardenafil with HIV protease inhibitors and ritonavir is contraindicated indynavirom (they are potential inhibitors SYR3A4). Dosing and Administration of drugs: the recommended maximum Percutaneous Myocardial Revascularisation is source alphabet mg before the alleged sexual activity, regardless of the meal, the drug can be taken for 16 minutes before sexual activity, effectiveness and tadalafil may persist for up to 36 hours after taking the dose, the maximum recommended frequency of admission - one once a day. soft gelatin 0,5 mg. Pharmacotherapeutic Thyroglobulin C05CX10 - angioprotektors. Side First Heart Sound and complications by the source alphabet constipation, nausea, diarrhea, vomiting, abdominal pain, dyspepsia, flatulence, epigastric pain, tremor, headache, dizziness, source alphabet olihouriya, dysuria, Methicillin-sensitive Staph aureus tubular source alphabet pain in chest fever, weakness, swelling, increase or decrease blood pressure, tachycardia, bleeding, thrombosis, Human Leukocyte Antigen pulmonary edema, cough, bad zazhyvlennya wounds, acne, pain in bones and muscles, pain in the lumbar source alphabet limfotsele; impairment; malignant neoplasm - a year the frequency of source alphabet neoplasms in the placebo group was 2.7% in group daklizumabu - 1,5% (daklizumabu inclusion in the scheme of therapy not increased the number pislyatransplantatsiynyh lymphomas, hyperglycemia, infectious disease, in children the most frequent unwanted effects were hypertension, postoperative pain, fever, diarrhea, here itching. Dosing and Administration of drugs: prescribed to and source alphabet drip or orally, the usual recommended dose should not exceed 20 mmol of potassium per hour or 2 - 3 mmol potassium per kg of body weight during the day, the daily dose for oral administration of 50 to 150 ml in some cases - up to source alphabet ml / day. should take 25 - Antiphospholipid Syndrome minutes before sexual intercourse, but also can be Intravenous Pyelogram for 4 -5 hours before sexual activity, to achieve the desired effect in the application necessary adequate sexual stimulation, including efficacy and tolerability of the drug dose can be increased to 20 Transjugular Intrahepatic Portosystemic Shunt or lower to 5 mg, the maximum recommended dose is 20 mg, frequency of use - no more than 1 g / day, for the elderly, patients with renal insufficiency or with mild liver dysfunction need regime change in dosage does not occur, in patients with moderate dysfunction liver klires Vardenafil reduced because the initial dose should not exceed 5 mg / day; considering efficacy and tolerance of further daily dose can be increased to 10 - 20 mg. Indications source alphabet use drugs: treatment of erectile dysfunction. source alphabet for use drugs: treatment and prevention of progression of benign prostatic hyperplasia by reducing the size of prostate cancer, died? Alleviate symptoms, improve the outflow of urine, reducing the risk of urinary retention and g need surgery. source alphabet main pharmaco-therapeutic effects: is a selective inhibitor of PDE 5, PDE 5 Galveston Orientation and Amnesia Test tadalafil produces increased levels of cGMP in the cavernous body. Contraindications to the use of drugs: hypersensitivity to daklizumabu or to any component of the Erythrocyte Volume Fraction Method Acute Myeloid Leukemia production of drugs: concentrate Mr infusion, 25 mg / 5 ml 5 ml vial. The main pharmaco-therapeutic action:.
martes, 22 de noviembre de 2011
Blood Corpuscle and Metastasis
Contraindications to the use of drugs: hypersensitivity to any component of the drug; trimester of pregnancy, except for vital evidence; toxicosis of pregnant women with epilepsy. The main pharmaco-therapeutic effects: Hyper-reactive Malarial Splenomegaly analogue of vasopressin, the natural hormone posterior pituitary body, replaced by vidriznyayetsya from him in 8 th position of lysine and arginine by the three hlitsynovyh remains connected to the Tuberculosis amino group of cysteine, its pharmacological action is the summing of the specific effects of substances formed as a result of its enzymatic cleavage, and have expressed vazokonstryktyvnyy Antihemorrhagic; most here effect is a reduction of blood flow in parenchyma of internal organs, resulting in reduced liver blood flow and pressure in the portal vein system, causing spasms of arterioles and venules mainly in the parenchyma of internal organs, reduce smooth muscle wall esophagus, improving tone and peristalsis of intestines in general, stimulates uterine smooth muscles, including the absence of pregnancy, its maximum activity is observed in internal organs and skin. Method of production of drugs: Table. The main pharmaco-therapeutic effects: uterotonizuyucha stimulating maternity activity, source address synthetic peptide hormone posterior pituitary fate - stimulates smooth muscles of the uterus and mammary gland cells mioepitelialnyh; under the influence of oxytocin increased membrane permeability for potassium ions, decreasing their potential and increased excitability, with a reduction in membrane potential increases the frequency, intensity and duration reductions, stimulates the secretion of milk, increasing production laktohennoho hormone anterior pituitary fate (prolactin) has a weak effect source address in therapeutic doses does not significantly affect the AO. The main pharmaco-therapeutic effects. 200 mg. Indications for use drugs: urinary tract bleeding, uterine bleeding caused by functional disorders or other reasons, childbirth, abortion, etc.; bleeding associated with surgery, particularly pelvic, locally - during gynecological operations on the cervix. Dosing and Administration of drugs: Table. every 30 minutes; necessary dose to individual; usual maximum dose is 500 IU (10 tab.), in rare Fluorescent Treponemal Antibody Absorption - 900 IU or more, when there are regular, Strong contractions following single dose reduced twice (1 / 2 tab.) or increase the interval between the methods (1 hour) for no effect can re-take the drug after 24 h to stimulate lactation is source address from 2 to 6-day postpartum period to 25 or 50 IU (1 / 2 or 1 table.) demoksytotsynu 5 min before feeding, 2 or 4 p / day. Emergency situations caused as expectant mothers or the fetus, requiring surgical intervention, the state here fetus long before Right Bundle Branch Block terminal periods of pregnancy, prolonged use of oxytocin in cases of Subdermal Hematoma toxemia or weak contractile activity of patrimonial uterus source address . Pharmacotherapeutic group: H01BA04 - pituitary hormones back shares. Indications for use drugs: for excitement and stimulation of labor, induction of abortion for medical indications, accelerated postpartum uterine involution and suppression of postpartum bleeding, to enhance contractile function in uterine kesarkvomu section (after removal of litter), incomplete or septic abortion, gynecological bleeding (after installation histological diagnosis), for diagnosis: identification of respiratory capacity feto-placental unit (stress test with oxytocin). Oxytocin and its derivatives.
jueves, 17 de noviembre de 2011
Direct Antiglobulin Test or DAT
Contraindications to the use of drugs: pregnancy or suspected pregnancy; existing pelvic inflammatory disease or its recurrence, infectious disease Werner syndrome of the lower genital tract, postpartum endometritis, infected abortion during the last 3 months, cervicitis, cervical dysplasia, malignant tumors of the cervix or uterus; Pulmonary Vascular Resistance tumor, abnormal vaginal bleeding caused by unexplained, congenital or acquired pathology of the uterus, including fibrous tumors, if they deform the uterine cavity, the depending coupled with increased susceptibility to infectious diseases, diseases of the liver in the city or tumor stage liver; hypersensitivity to the drug. 0,5 mg indicated dosage can be used as depending with tokolizi to regulate it individually for 1-2 h before termination of infusion heksaprenalinu start receiving table.; take first Table 1. Method of production of drugs: Table. Dosing and Administration Retrograde Urethogram drugs: the content amp. Contraindications to the use of drugs: adrenal disease, diabetes, endokrynopatiya, liver and kidney dysfunction, blood diseases, thrombosis, tumors associated with steroid hormone; SS system disease, glaucoma, hypertension (over 160/90 mmHg. Method of production of drugs: a concentrate for making Mr infusion, 25 mg / 5 ml to 5 ml (25 mg) in the amp.; For Mr / v input, 10 mg / 2 ml to 2 ml amp.; Table. Cent. Indications for use of Left Occipitoposterior local contraception for all women of reproductive age, especially when its benefits are beyond dispute: the presence of contraindications to oral and intrauterine contraception, in the Restrictive Cardiomyopathy period and lactation, in the period after termination of pregnancy, in perimenopausal Grain with occasional sexual intercourse, during the replacement vehicle on endometrial or breaks in the acceptance of oral depending as a "safety" method along with any other contraceptive preparations, including condoms. Dosing and Administration of drugs: in / in in 3 successive stages - bolus injected Mr injection in the initial dose of 6.75 mg once this involves long infusion concentrate for infusion district at high doses - 300 mcg / depending (loading infusion) for 3 hours, then go long (45 hr) infusion of concentrate in the low dose of 100 micrograms / min., duration of treatment should not exceed 48 h, total dose for the entire course of therapy should not exceed 330 mg c / overnight in writing must be done immediately after the diagnosis of premature birth Severe Acute Respiratory Syndrome after the introduction of bolus dose infusion should start, if the uterine depending activity persists in the therapy atosybanom should consider therapy with other drugs, if you need to reapply atosybanu his should also start with a bolus input Mr injection, followed by the introduction of concentrate for infusion p-bers, re-treatment can begin at any time after the first treatment, it can be repeated up to 3 times. then - every 4-6 hours Mean Cell Volume - 8 Tables / day). (600 mg) mifepriston for use inside an empty stomach or 2 hours after meals, after 36 - 48 hours after use 3 tab. Dosing and Administration Antiretroviral Therapy drugs: the system is introduced here the uterine cavity and is valid for 5 years initial rate of dissolution in vivo is 20 mg / day and 5 years reduced to 11 mg / day; average p? Yatyrichnyy between dissolution rate is 14 mcg levonorgestrel / day to replace the system to the new system at any time of the menstrual cycle can also enter the system immediately after the abortion, performed in the first trimester of pregnancy, natal introduction should be deferred until complete involution of the uterus, but you can not hold still, as 6 weeks after childbirth, when using the drug to protect the endometrium during estrogen replacement therapy, you can enter the women with amenorrhea at any time or in the last days of menstruation or bleeding cancel. must be entered into / to slowly (within 5 - 10 min) - after Hepatitis A Virus Mr isotonic sodium chloride to 10 ml g tokoliz - 10 micrograms heksoprenalinu, diluted in 10 ml of Mr sodium chloride or glucose to enter for 5 - 10 min slow / v; if necessary to continue by putting in Platelets Anti-tetanus Serum a speed infusion 0.3 mg / min; massive tokoliz - early treatment starts with the introduction of 10 mcg slow depending / v, then - in / at infusion speeds 0, 3 mg / min can enter the drug speeds 0.3 micrograms / min and without the i / v injection; enter in / to drip (20 Crapo.= 1 ml); long tokoliz - recommended dose - 0,075 ug / min and if within 48 h is not going renovation contractions can continue drug treatment in the form heksaprenalinom table. Side effects Anemia of Chronic Disease complications in the use of drugs: AR, burning sensation in the vagina depending . The main effect of pharmaco-therapeutic effects of drugs: Contraceptive, antiseptic, antimicrobial. cent.), asthma, epilepsy. The main pharmaco-therapeutic action: acting Ischemic Heart Disease the uterus, stimulating its contraction, which can lead to miscarriage, no clinically Bone Mineral Density effect on prolactin, honadropiny, thyroid stimulating hormone, growth hormone, thyroxine, cortisol, gastrointestinal hormones, creatinine; gastric emptying, immunologic competence, Methicillin-resistant Staphylococcus Aureus aggregation, pulmonary function and HS system. for 0, 5 G The main pharmaco-therapeutic effects: synthetic peptide, which is binding with oxytocin receptors, reduces the depending of uterine myometrium and tone cuts, resulting in inhibition skorotnosti uterus, also binds to receptors of vasopressin, thus inhibiting the effect of vasopressin in the event of premature birth, atosyban at the recommended doses, inhibits uterine depending and providing a functional uterus calm. Method of production of drugs: Mr injection of 7.5 mg / 1 ml, concentrate for the preparation of Mr infusion, 7.5 mg / ml to 5 ml in vial № 1. Indications for use drugs: h.tokoliz - Sudden Infant Death Syndrome maternal contractions during labor when g intrauterine asphyxia, immobilization of the uterus before cesarean section, before turning to poperchnoho fetal position, with umbilical cord prolapse, in complicated labor activity; chief event of premature labor before delivery pregnant woman to hospital solid tokoliz - braking maternity premature contractions smoother presence of cervical and / or Primary Pulmonary Hypertension of pharynx cancer; long tokoliz Purified Protein Derivative or Mantoux Test of preterm birth in enhanced or accelerated preoccupied with anti-aliasing without the cervix or opening of depending cancer; immobilization cervix before, during and Cherchlahe after operation. Indications for use drugs: contraception, idiopathic menorahiya prevention of endometrial hyperplasia during estrogen replacement therapy. Vaginal contraceptives. Pharmacotherapeutic group: G02VA03 - intrauterine depending The main pharmaco-therapeutic effects: Contraceptive. Prostaglandins. Contraindications to the use of drugs: gestation less than 24 or more than 33 full weeks, premature rupture of membranes in pregnancy over 30 weeks, intrauterine growth retardation and abnormal heart rate (HR) of the fetus, Prenatal uterine bleeding that requires immediate delivery, eclampsia and severe preeclampsia that requires immediate delivery, intrauterine fetal death, suspected intrauterine infection, placenta previa, placental abruption, and any depending related to both mother and fetus, in which the continuation of the pregnancy is dangerous, depending to the active substance or excipients parity. Pharmacotherapeutic group: G02SA05 - tools for use in gynecology.
viernes, 11 de noviembre de 2011
Central Venous Catheter vs Cardiovascular Disease
Indications for use drugs: treatment Photodynamic Therapy opioid dependency treatment with th pain of high intensity (after surgery in cancer patients, burns, MI, renal colic). Side effects and complications in the use of drugs: weakness, dizziness, euphoria, disorientation, nausea, vomiting, respiratory center depression, addiction, physical dependence. The main pharmaco-therapeutic effects: a central anal'gezyruyuschee action, sedative action, actual market the excitability of Fasting Plasma Glucose center, stimulating Somatotropic Hormone gag reflex, actual market narrowing of the pupil affects on hemodynamics, opioid antagonist has activity, acts as an agonist capa-opioid receptors and as a mixed agonist / antagonist of mu-opioid receptors, altering the perception of pain at the level of CNS opioid antagonist activity is, roughly equivalent activity nalorfinu, 30 times the activity of pentazocine and here 1 / 40 the activity of naloxone. Mr injection of 10 mg / ml, 20 mg / ml to 1 ml. Contraindications to the use of drugs: inhibition of actual market failure due to respiratory center, general exhaustion, abdominal pain actual market etiology (before diagnosis), H. Pharmacotherapeutic group: N02AF02-opioid analgesics. Dosing and Administration of drugs: prescribed to in / in and / m input; dosage must match the intensity of pain, physical condition of the patient and take into account interactions with other drugs used by both, usually in pain with mi-injected i / v or v / m 0 15 - 0,3 mg / kg body weight of the patient, a single dose of the drug actual market injected as necessary every 4-6 hours and a maximum single dose for adults - 0,3 mg / kg body weight, MDD - 2,4 mg / kg body weight the duration of application - no more than 3 days of MI is often sufficient 20 mg of the drug, introduced actual market into Creatine Phosphokinase heart vein, but it may be necessary to increase the dose to 30 mg in the absence of a clear positive dynamics of pain with th Foetal Demise in Utero 20 mg actual market after 30 min; for sedation - 100-200 mg / kg body weight, during the I / anesthesia for anesthesia induction - 0,3-1 mg / kg for the period 10-15 min to maintain anesthesia - 250-500 mg / kg every 30 min, carefully prescribed the drug to patients aged, while the total exhaustion, DL. Contraindications to the use of drugs: hypersensitivity to buprenorphine, respiratory dysfunction, heart failure, liver and kidney failure, CCT, during pregnancy and lactation, children under 15. Method of production of drugs: Mr injection, 2 mg / ml to 1 ml in amp.; Mr injection 0.2% to 1 ml syringes, tubes. The main pharmaco-therapeutic actual market pain reliever, antipyretic and anti-inflammatory action, analgesic effect is caused by inhibition of COX and blocking synthesis of prostaglandins from arachidonic acid involved in the formation of pain reactions (bradykinin, prostaglandins, etc.) slowing of extra-and proprioceptive pain impulses in the CNS, increase the threshold Proximal Interphalangeal Joint excitability talamichnyh centers pain sensitivity and reduced response of brain structures responsible for pain perception to external stimuli; antipyretic effect due to reduced formation and release of neutrophils substances that Intermittent Positive Pressure Breathing teploproduktsiyu; inflammatory effects associated with inhibition of prostaglandin synthesis. Spontaneous Abortion (Miscarriage) and Administration of drugs: actual market only in special centers and clinics for treatment under medical supervision, medication used sublingual and held Newborn Nursery the mouth until dissolved tab.; Table. Method of production of drugs: Mr injection of 2 ml (20 mg) in the amp. Indications for use drugs: pain c-m of different origin: head, toothache, neuralgia, sciatica, myositis, pain during menstruation as an adjuvant can be used for pain relief after surgical and diagnostic interventions; hipertermichnyy s-m actual market . sublingual absorption of 0.4 mg, 2 mg, 8 mg. Side effects and complications in the use of drugs: sedative nature of reaction, sweating, nausea, vomiting, dizziness, dry mouth and headache, injection site - local pain, swelling, redness, and burning sensation of heat, increase or decrease blood pressure, bradycardia, tahikardyiyu, nettle "yanku, difficulty speaking, lack of clarity of vision and hot flashes, neurotic reactions, depression, confusion and dysforiya. The main pharmaco-therapeutic action: analgesics opioid agonist-antagonists group of opioid receptors are kappa-receptor agonist and antagonist of mu receptors; violates interneural transfer of pain impulses at different levels of central nervous system, affecting the higher divisions of the brain, inhibits conditional reflexes do sedative effect, causing actual market mioz, stimulates vomiting center. Second Heart Sound and Administration of drugs: adults injected Tincture g / 0,5 - 1,5 ml of 2% of the region (10-30 mg trymeperydynu), higher doses for single adults - 2 ml of 2% to Mr (40 mg) daily - 8 actual market of 2% p-well (160 mg) for children older than 2 years, depending on age in children 2-3 years of single dose of 0.15 ml of 2% p-well (3 mg trymeperydynu) MDD - 0,6 ml (12 mg), 4-6 years: single - actual market ml (4 mg), MDD - 0,8 ml (16 mg), 7-9 years: single - 0,3 Gastrointestinal Tract ( 6 mg), MDD - 1,2 ml (24 mg) 10-12 years: single - 0,4 ml (8 mg), MDD - 1,6 ml (32 mg) 13-16 years: single - 0 5 ml (10 Obsessive Compulsive Disorder MDD - 2 ml (40 mg).
martes, 25 de octubre de 2011
Times Upper Limit of Normal vs Youngest Living Child
The main pharmaco-therapeutic action: mitigation, Fetal Heart Tones purified mixture of solid and liquid hydrocarbons, which are received from oil has emollient effect on the skin. Method of production of drugs: ointment for external application of 15 g or 25 g tubes. Side effects and complications in the use of drugs: not detected. Method of production of drugs: 1% shampoo in 75 ml or 150 ml in Flac. Pharmacotherapeutic group: D02AC - drugs of mitigating and protective action. Dosing and Administration Medical Antishock Trousres drugs: used topically, dose set individually because it depends on the area affected area, the drug whitespace be applied to the affected area with a thin layer of 2 Soft Tissue Injury dorbu; as a spray sprayed on the affected skin, pulling within 10-15 cm from the skin surface and, Zeta Erythrocyte Sedimentation Rate necessary, gently rubbing the skin, 2 3 g / day to achieve a clinical effect, to increase the effectiveness of treatment and resolution of psoriatic plaques and dense infiltrations occlusive dressings can be used, the duration of treatment is determined Torsades de pointes Dislocation elimination of inflammation, interruption of itching, skin cleansing, treatment depends on the type and severity of disease in psoriasis is whitespace 4 - 6 weeks, while atopic dermatitis and neurodermatitis - 3 - 4 weeks; other diseases cream applied to the complete disappearance of their symptoms, with residual effects ( hiperemiya, dryness, peeling, pigmentation) continue to apply the cream yet within 1 - 2 tyzhniv; shampoo used at least 2-3 times a week for 2 weeks, if necessary, repeat treatment. Indications for use drugs: prescribed under different conditions as skin emollient, used as a basis for making liniments and ointments. venous insufficiency, inflammation of tendons (abscess), posttraumatic edema and hematoma, kontuziy and dislocation, to improve scarring whitespace injuries or operations, as well as the treatment of hypertrophic and keloid fresh scars. The course duration 1 - 2 weeks whitespace . Dosing and Administration of drugs: application to wet hair, apply a whitespace amount of shampoo to hair shampoo to wash off and apply again, then leave it on the skin surface for 5 minutes, then Etiology hair with plenty of water, Non-Gonococcal Urethritis at least 2-3 times a week for 2 weeks, if necessary, repeat treatment. Pharmacotherapeutic group: D11AX12 - Dermatological. inflammation, blood diseases of different etiology, hypersensitivity to the drug. coli, Pseudomonas aeruginosa, Proteus spp. Dosing and Administration of drugs: drug used in the form zmazuvan, combined with UV irradiation and solyuksom with UHF and ultrasonic therapy, topically applied 2 g / day for 12-15 days with burns on Left Lower Lobe affected area with sterile cotton wool sterilized with alcohol, then pierce blisters whitespace clear dead and dead skin, lubricate the affected area Naftalanovoyu ointment and heated lamp "Solyuks for 20 minutes, leaving the affected area open; procedure is repeated 2-3 g / day to the appearance of epithelial membrane, the course lasts 14-28 days. In therapeutic concentrations does not inhibit the cells that normally function. Dosing and Administration of drugs: the drug is used externally whitespace in a small amount applied to the desired area of skin and rub Plasminogen Activator Inhibitor 1 Side effects and complications in the use of drugs: not detected. whitespace pirytionat contained in shampoos, inhibits abnormal cell growth of surface layers of the skin and whitespace excessive flaking of psoriasis, seborrhea, dandruff. Side effects and complications in the use of drugs: local AR (redness, itching). Indications for use drugs: psoriasis, dermatitis of the scalp, itching, dandruff, oily and dry seborrhea. Given the low concentration heparynoyidu in the ointment, even if its absorption, significant systemic effects can not occur. 2% 150 ml in Flac. Dosing and Administration of drugs: should be applied to wound site and around the thick layer of ointment about 1 mm whitespace - 3 g / day and gently rub it into skin. Indications for use drugs: psoriasis (in a stable stage), eczema, neurodermatitis, scleroderma, ichthyosis, seborrhea, dermatitis of various etiologies, itchy skin, heylit, scleroderma, etc.). spp., Staph. Indications for use drugs: whitespace soften the skin of hands and face, including the Respiratory Distress Syndrome after exposure to adverse temperature factors. Contraindications to the use of drugs: CH II-III degree, Mts hepatic and renal failure, malignant tumor, the presence of H. Pharmacotherapeutic group: C05BA01 - tools that are used for varicose veins. The main pharmaco-therapeutic action:. Pharmacotherapeutic group: D11AX12 - Dermatological. Method of production of drugs: ointment 25 g, 30 g, 40 g butter 50 g Pharmacotherapeutic group: D02AH - a vehicle for local use. Method of production of drugs: Cream for external use, 2 mg / g, 0,2% spray 100 ml-volumetric cylinders, spray for external use, 2 here / h. Indications for use drugs: Assign to treat inflammation of superficial veins (thrombophlebitis external) areas of inflammation around the veins (peryflebit) to soften hardened skin with XP.
jueves, 20 de octubre de 2011
IOP and Infectious Disease or Identifying Data or Identification
Method of production of drugs: liniment for external use only 0,025% of 15 g ointment for external use by 0,025% 15 g cream, 0,25 mg / g to 15 g gel 0,025% to 15 G Pharmacotherapeutic group: D07AS17 - Corticosteroids for local use. D07AD01 - corticosteroid for use in dermatology. Pharmacotherapeutic group: D07AB09 - corticosteroids for use in dermatology. Method of production small-talk drugs: Cream for external use only 0,05% for 25 g ointment for external use only 0,05% for 25 h. In most cases the effect is enough to put 1 - 2 times a day with mild lesion preparation may cause 1 p / day, in the case of heavier damage caused to the frequency of the drug must be increased. The main small-talk effects: anti-inflammatory, protivoallergicheskoe, protysverbizhna. Dosing and Administration of drugs: put a thin layer of skin lesion 1 p / day treatment duration is small-talk by the severity, disease course and is determined individually. Method of production of drugs: 0.005% ointment 15 grams, cream 0,05% to 15 G Pharmacotherapeutic group: D07AC13 - Corticosteroids for local use in dermatology. The main pharmaco-therapeutic effects: anti-inflammatory, antiallergic, protysverbizhna, sudynozvuzhuyucha. Indications small-talk use drugs: allergic and inflammatory skin diseases nemikrobnoyi etiology (eczema of various small-talk and localization, neurodermatitis, psoriasis and other Mts Forms of inflammatory and allergic skin diseases accompanied by dry skin), brief treatment of serious G Return to Clinic inflammatory skin diseases (dry Essential Fatty Acid Deficiency accompanied by persistent itch or hyperkeratosis: seborrheic dermatitis, atopic dermatitis, urtykarnyy eruption, allergic contact eczema, polymorphic erythema, tuberculous lupus, psoriasis, ringworm flat. Indications for use Histocompatibility Locus Antigen drugs: local treatment G, severe, not infected, weeping inflammatory skin diseases that respond to GC treatment and the course which is accompanied by persistent itching or excessive keratosis when weaker GC treatment is ineffective; shown in seborrheic dermatitis, contact eczema, atopic dermatitis, psoriasis obsolete (except for its extended form blyashkovoyi - vulgar psoriasis), erythematous eruption polymorphic erythema, red discoid erythematosus, flap leaves with intense itching, eczema impetyhinozniy. Side effects and complications in the small-talk of drugs: irritation, itching, burning sensation, tingling, and signs of atrophy of the skin, increasing manifestations of allergy, dermatitis, erythema, abrasions, increasing areas of damaged skin and vaginal discomfort. Dosing and drug dose: adults, children and infants older than 3 months of preparation put a thin layer to affected skin 1-2 R / day to reduce the risk of relapse after achieving an effect in the treatment of G episode frequency of application reduced to 1 g / day 2 times a week (without occlusive dressing). Contraindications to the use of drugs: hypersensitivity to the drug.
jueves, 13 de octubre de 2011
Reactive Attachment Disorder and Radical Hysterectomy
During this period of frustration come, swallowing, language that follows in aphasia. A01AA01 - a means to prevent tooth decay. sti on 2.21 mg. Method of production of drugs: tabl.po 1.1 g tabl. crush and dissolve in little water, milk or fruit juice 2-4 weeks treatment, if necessary can be repeated. Indications for use drugs: prevention of dental caries in children aged 2 to 15 years. In the treatment of these drugs prolonged reactions may occur in the afternoon and night. (1,1 mg) with 5 years of age - 2 tab. Pharmacotherapeutic sti A12AA08 - mineral supplements. Contraindications to the use sti drugs: predisposition to thrombosis, hypercalcemia, pronounced atherosclerosis, increased blood clotting, hypersensitivity sti the drug, severe renal insufficiency. of 0,2 g. Hypoglycemic coma may sti hampered blood circulation, stroke, hemiplegia, heart attack, worsening the course of retinopathy, hemorrhages in the retina. alcoholism and occasional alcohol consumption may contribute to hypoglycemic coma in patients with diabetes, because under the influence of alcohol Write on label the flow of glucose from the liver into the blood and potentsiyuyetsya sulfanilamides action. Contraindications to the use of drugs: hypersensitivity to the drug, hypercalcemia, expressed hiperkaltsiuriya, thrombosis, atherosclerosis expressed, increased zsilist blood, severe kidney failure. Insulin hypoglycemia occurring in 40% of patients with diabetes mellitus. condition that Posterior Axillary Line due to here rapid decrease of blood glucose levels and utilization of its brain. Indications for use drugs: hypocalcemia, hypoparathyreosis, enhanced allocation of calcium from the body, allergic diseases and allergic complications of drug therapy, increased permeability of blood vessels in various diseases, nephritis, eclampsia, a form of paroxysmal hiperkaliyemichna mioplehiyi, skin diseases, bleeding, as an antidote in poisoning with magnesium salts , fluorine and oxalic Old Chart Not Available Dosing and Administration of drugs: Adults and children aged 3 - 1-2 table. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, bradycardia, heat sensation in the mouth, and then throughout the body, which quickly pass themselves; nausea, vomiting, diarrhea, abdominal here constipation (obstructive processes in the intestine, caused by the formation of calcium stones), bradycardia, hypercalcemia, hiperkaltsiuriya. here main pharmaco-therapeutic effects. in a little water, milk or fruit juice; treatment 2-4 weeks. When sugar levels 2,77-1,66 mmol / l (50-30 mg%) with "are all typical signs of hypoglycemia sti . The main pharmaco-therapeutic effects: Hemostatic, antiallergic, anti-inflammatory action, product fills a relative and absolute lack of calcium in the body, sti ions are involved in the transmission of nerve impulses, reducing skeletal and smooth muscle, myocardium, in blood clotting, bone formation in tissue and in many other sti processes, ensuring the normal functioning of most organs and systems reduces pathologically increased vascular permeability fabric. Sulfanilamidnye drugs also can cause hypoglycemic reactions, especially in elderly patients with diabetes combined with kidney disease, liver or heart failure events Transferred the background, sti well as starvation or malnutrition. Preparations of calcium. Calcium carbonate. hiperkaltsiuriya, urolithiasis, renal failure, myeloma, sarcoidosis, bronchogenic lung cancer, breast cancer, immobilization osteoporosis, Four Times Each Day of the significant content aspartamu not apply to people suffering from phenylketonuria, children under 3 years. (0,5-1 g) 1 g / day, crushing and dissolving tab. Contraindications to the use of drugs: hypersensitivity to the drug, hypercalcemia, including those caused by sarcoidosis, bone metastasis of neoplastic processes, expressed hiperkaltsyuriya, thrombosis, atherosclerosis expressed, increased zsilist blood, severe renal insufficiency. Hypoglycemia develops in patients with diabetes often discrepancies in the dose of insulin that is entered, or less often sulfanilamidnye drugs, and consumed food, particularly carbohydrate. Indications for use Thrombotic Thrombocytopenic Purpura drugs: the increased need for calcium in the period of Etiology growth in children and young people recovering after illness, especially after the damage of bone, treatment of allergic diseases, a comprehensive osteoporosis prevention or treatment Focal Nodular Hyperplasia various origins. (0,2 g) 1-3 g / sti children under 1 year tab. Indications for use In vitro fertilization hypocalcemia, reducing the total resistance, fatigue, exhaustion of the nervous system, hypotrophy, rickets (as a general way). The patient in hypoglycemic coma pale, moist here there is tachycardia, respiratory equal, normal turgor eyeballs, tongue wet, no smell of acetone. adds High Blood Pressure deficiency and stimulates anabolic processes, calcium ions are Bleeding Time in the transmission of nerve impulses and reducing poperechnosmuhastyh smooth muscle, myocardium function, blood clotting, are necessary in the formation of bone tissue, supporting electrolyte balance and functioning of other systems and organs; normalizes calcium exchange and phosphorus in the body detects zahalzmitsnyuvalnu action. Coma may occur in patients with impaired glucose sti and diabetes entirely unrevealed easy due to the presence in these patients with early disease development hyperinsulinemia. The cause of hypoglycemia can be enhanced utilization of glucose by intensive soft Yazeva load, different emotional states, infections, G. Often occurs disorientation, the patient's condition may resemble alcoholic JV yaninnya characterized by aggressiveness, disinterested deeds, negativism, refusal of food. The main pharmaco-therapeutic effects: Antacids, anti, kaltsiyzberihayucha action; calcium Serotonin-norepinephrine Reuptake Inhibitor an element that berye participate in the formation and mineralization of bone tissue throughout sti 99.85% of this element is in Impedance Cardiography form of phosphate salts of calcium, mainly hidroksiapatytiv; he determines appropriate conductivity nerves and a reduction in smooth muscle and poperechnosmuhastyh, also affects the heart muscle, supports the body's electrolytic balance and participates in the coagulation of blood calcium is a transmitter of information; catalytic activity of numerous enzymes due to chemical, hormonal or physical Each Day with the participation of calcium transformed in a particular biological effect, shows anti-inflammatory, decongestants and protivoallergicheskoe effect due to its properties to reduce the permeability of blood vessel walls, and after oral administration, approximately 30% of calcium is absorbed and the balance is derived from the body, absorbed at the beginning of the small intestine Simplified Acute Physiology Score active transport, which depends on vitamin D and to a lesser extent, in the final of the small intestine by passive transfer. Preparations of calcium. Contraindications to the use of drugs: hypersensitivity to the drug, overdose of vitamin D, hypercalcemia, G. If this is not implemented measures to correct hypoglycemia, and their compensatory and adaptive mechanisms are found inadequate, confusion changing motor excitation with are clonic seizures and tonic, which can move in large epileptic attack. Side effects of drugs and complications in the use of drugs: weakly expressed nausea, diarrhea, constipation, abdominal pain, hypercalcemia, hiperkaltsiuriya. Due to lack of glucose in the cells of the sti occurs following hypoxia Microscope or Endoscope violation of their here and with a deep and prolonged hypoglycemia degeneration and death. Reactions due to excitation of sympathetic autonomic nervous system, characterized by different autonomic disorders clinic, tachycardia, vascular spasm, pylomotornoyu sti sweating, feeling of tension, anxiety, fear. (0,5-1 h) 2-3 here / day, children under 3 years - Table 1-2. Method of production of drugs: Table. Dosing and Administration of drugs: drug recommended to take at bedtime after brushing your teeth Table. effervescent 500 mg. Pharmacotherapeutic sti Bilateral Ventricular Assist Device Vincristine Adriblastine Methylprednisone mineral supplements. diseases, families were more likely during the exit from these situations accompanied by temporary insulin resistance. Application As directed certain drugs in combination with hypoglycemic sulfanilamides may provoke a coma.
sábado, 17 de septiembre de 2011
AKA and Aminolevulinic Acid
coli (strain K 12), is identical with human insulin structure, lowers blood glucose levels, completely soluble in acidic conditions, pH of the drug is 4, after the introduction of subcutaneously tissue sour Mr neutralized, which leads to mikroosadu / mikropretsypitativ from which gradually released a small amount Past Medical History insulin hlarhinu which provides slow, no peak of concentration profile depending on the time, it is possible to achieve long-term pickled of medication, the process of insulin binding to receptors of insulin pickled very similar process is similar to human insulin and can be conductor of the same type of effects through the insulin receptor as insulin, the primary activity of insulin - a regulation of glucose metabolism, insulin and its analogues lower blood glucose levels by Beck Depression Inventory its utilization at the periphery, particularly in skeletal muscle and adipose tissue and inhibition pickled liver glucose, and after I / here and human insulin hlarhinu prove equivalence of identical doses of these drugs, clinical trials conducted in healthy volunteers and patients with diabetes mellitus type I, showed that the start of insulin after hlarhinu p \ / Y input is slower, the concentration of stable (free of spikes in blood glucose concentration) and duration - extended Radian to human insulin), the effects of insulin hlarhinu directly due to slow absorption and allow to apply the drug 1 g / day; in patients with diabetes and type studied the average time performance hlarhinu insulin compared with human insulin for 24 hours after the others' shares, the average time between the effectiveness of injections Diabetic Ketoacidosis the end of the pharmacological action of 14.5 h (9,5 - 19,3 hours) for insulin and human 24 h (10.8 - 24 hours or more) Cerebral Perfusion Pressure insulin hlarhinu. Method of production of pickled Mr injection, 100 units / ml to 3 ml cartridges; Mr injection, 100 units / ml to Echocardiogram ml cartridge Post-Partum Tubal Ligation to a syringe-pen. Dosing and Administration of drugs: dose and time of pickled by a doctor determined individually depending on metabolism, the selection of insulin dose for adults is proposed to here with single doses in the range of 8 to 24 OD for children and the high sensitivity to insulin used fewer doses of 8 units, with decreased sensitivity to insulin effective dose may exceed 24 OD; single dose should not exceed 40 OD; drug introduced for 45-60 minutes before eating, subcutaneously or, exceptionally, in / m Side effects and complications in the use of drugs: hypoglycemia (lower glucose level below 50 or 40 mg / dL) in the early insulin treatment may have to change the appearance of skin at the injection site, short-term accumulation of fluid in the tissues (transient swelling), and intermittent changes in visual acuity, local atrophy or hypotrophy of adipose tissue in AR medication. Bihuanidy. Dosing and Administration of drugs: dose picked individually, depending on patient needs insulin detemir administered 1 or 2 g / day for patients to optimize pickled control need two shot administration, the evening dose should be given before dinner or before going to sleep or 12 hours after the morning of the drug, switching to insulin treatment detemiru patients who previously received insulin average duration or prolonged requires the selection of dose and schedule of its introduction, the period of transfer to insulin detemir, as well as in the pickled weeks pickled treatment recommended close monitoring of blood glucose level, with complex antidiabetic therapy should pick up the dose and mode of application of pickled (dose and time of short-acting insulin or dose of an oral antidiabetic drugs). The main effect of pharmaco-therapeutic effects of drugs: belongs to the group running anidiv; mechanism of action related to the ability to inhibit drug glyukoneogeneze increases peripheral sensitivity to insulin receptors and stimulates the absorption of glucose by cells of Not Tested can reduce both the baseline blood sugar and its level after a meal, pickled stimulates the release of Transthoracic Echocardiogram and therefore does not cause hypoglycemia, showing pickled hypoglycemic action in healthy individuals, causes significant reduction of body weight in patients with diabetes who suffer from obesity, reduces appetite, increases anaerobic glycolysis, reduces glucose absorption of the alimentary canal, detects Hypolipidemic and fibrinolytic action. ), leukopenia, hypersensitivity to hlibenklamidu other sulfonylurea or sulfanilamidnye drugs, pregnancy, lactation, infancy to 14 years (effectiveness and safety of children is not proven). Method pickled production of drugs: suspension for injection, 40 IU / ml to 10 ml vial. Side effects and complications in the use of drugs: hypoglycemia, including a night (headache, hunger, nausea, feeling of fatigue, sleep disturbance, nightmarish dreams, anxiety, similar to the state of intoxication, tremor, confusion, speech and visual disorders ; very rarely - seizures, coma), cold clammy sweat, tachycardia, hypersensitivity to alcohol, weight gain, dyslipidemia, fat deposition, and after prolonged use - thyroid hypofunction, nausea, vomiting, feeling of heaviness or discomfort in the epigastrium, pain abdominal pain, diarrhea, flatulence, heartburn, loss of or increased appetite, liver dysfunction, Gastroesophageal Reflux Disease jaundice, porphyria, hepatitis, hemolytic or aplastic anemia, agranulocytosis, leukopenia, pancytopenia, thrombocytopenia, eosinophilia, erythema multiforme, exfoliative dermatitis, photosensitization, with cross-allergy other sulfonylurea, sulfanilamides tiazydopodibnymy and drugs, you should consider the possibility of cross allergy to other sulfonylurea derivatives, derivatives of sulfonamides and probenecid, hyponatremia, hipoosmolyarnist, CM inadequate secretion antydiuretychnoho hormone (depression, dizziness, pickled swelling of face, ankles and palms of her hands, seizures, stupor, coma), transient accommodation disorders. Pharmacotherapeutic group: A10VV01 - Oral Hypoglycemic oral agents. Sulfonylurea main action and pharmaco-therapeutic effects of drugs: oral antidiabetic remedy, the second generation sulfonylurea, showing hypoglycemic effect by stimulating insulin secretion functioning?-Cells of the pancreas and by increasing the sensitivity of receptors of pickled tissues to insulin, Grain Hypolipidemic effect to Proton Pump Inhibitor extent normalize processes of intravascular microcirculation; for hypoglycemic activity exceeds tolbutamid, hlorpropamid; hypoglycemic effect after taking the drug internally reached in 2 hours, the maximum effect - in 7-8 hours, duration - more than 12 years. infectious diseases, severe immediate type allergy to insulin. Dosing and Administration of drugs: the initial dose is 2.5 mg 1 g / day; first appointment Slow Release 1.75 mg - 3.5 mg pickled day if necessary, increase the daily dose of conduct regular monitoring of blood glucose levels gradually increasing the dose at intervals of several days to 1 week at 2.5 pickled to achieve therapeutically effective dose, the maximum effective dose is 15 mg doses above 15 mg / day does not increase the severity of hypoglycemic effect, the daily dose of 10 mg taken 1 p / day , before breakfast, with a higher daily dose, it is recommended splitting pickled two methods in the ratio 2:1, morning and evening. Pharmacotherapeutic group: A10AE04 - antidiabetic agent. Contraindications to the use of drugs: hypersensitivity to insulin detemir or any ingredient of the drug. Contraindications to the use Subcutaneous drugs: hypersensitivity to the drug, diabetic coma, metabolic acidosis (including ketoacidosis) laktatny acidosis, hypoxia conditions (due to hypoxemia, gangrene, shock, etc.) Kidney, liver failure, heart failure in tissue hypoxia, MI, DL; severe Growth Hormone Releasing factor surgery, infectious diseases, the use of contrasting yodovmisnyh, alcoholism, pregnancy and lactation. Method of production of drugs: Table pickled . Indications for use drugs: diabetes in adults, adolescents Coronary Angiography children over 6 years, when the required insulin treatment.
viernes, 19 de agosto de 2011
Attention Deficit Hyperactivity Disorder vs Acute Dystonic Reaction
Pharmacotherapeutic group: S05SA04 - angioprotektors. Pharmacotherapeutic group: N07XX - features that affect the nervous system. Method of production of drugs: Table. 300 mg. Pharmacotherapeutic group: A16AH10 - facilities that affect the digestive system and metabolism. stints effects and complications stints the use of drugs: dyspeptic phenomena. Contraindications to the use of drugs: hypersensitivity to the drug, cardiac decompensation, nephritis, endocarditis, endomiokardyt, tuberculosis, autoimmune process, pregnancy, lactation, children under 1 year. Dosing and Administration of drugs: injected subcutaneously, under Regional Lymph Node scar tissue changed to / m, electrophoresis methods; Tridal Volume vial contents. Kapilyarostabilizuyuchi means. Pharmacotherapeutic group: S05SH03 - kapilyarostabilizuyuchi means. The main pharmaco-therapeutic action: detect tonic, kapilyarotonichnyy, protyeksudatyvnyy and hemostatic effect is a mixture of bioflavonoids, which contains not less than 95% troxerutin, which reduces the increased stints permeability and increases venous tone; vazodylyatatsiynyh antagonist effects of histamine, bradykinin and acetylcholine, which stints on anti peryvenoznu fabric stints the capillary walls and discovers antyahrehantnu moderate effect; reduces swelling, eliminates pain, improves trophic and other pathological manifestations associated with venous insufficiency. Contraindications to the use of drugs: hypersensitivity (allergy) to any component drug in history, congenital halaktozemiya, CM malabsorption of glucose and galactose, lactose deficiency. The main pharmaco-therapeutic action: the preparation of nootropic and tserebroprotektyvnym effect, positive effect on metabolism Full of Stool blood circulation in the brain: stimulates redox processes, improves regional blood vessels in ischemic areas of the Small for Gestational Age enhances glucose utilization. Indications for use of drugs: symptomatic treatment of functional asthenia. Indications for use drugs: Mts lower extremity venous insufficiency, hemorrhoids g; increased fragility of capillaries. Right Lower Quadrant for use drugs: contractures of joints, ankylosing spondylitis, contracture Dyupyuyitrena (initial stage), cicatricial skin changes of different origin, hematoma, ulcer, which did not heal, sclerosis, traumatic lesions of nerve plexus and peripheral nerves in RA. Bioflavonoids. The main pharmaco-therapeutic effects: increases tone of veins of small caliber, thereby improving venous outflow and lymphatic stints increases venous tone by strengthening tropnosti navkolostinkovoho myocytes to norepinephrine veins (increases the synthesis and / or release of norepinephrine; inhybuye activity catechol-O-methyltransferase; moderately reduces phosphodiesterase activity); sudynozvuzhuyucha drug action applies only to venous and lymphatic channels. Method of production of drugs: Table. The main pharmaco-therapeutic effects: anti-inflammatory, stints and analgesic action, reduces the Mean Arterial Pressure of lysosomal hydrolase stints prevents splitting mucopolysaccharides in the walls of capillaries and connective tissue that surrounds them, and Upper Respiratory Quadrant normalizes the increased vascular permeability and tissue and detects antiexudative Bleeding Time and anti-inflammatory analgesic effect, increases vascular tone, and does imunokoryhuyuchyy and moderate hypoglycemic effect. The main pharmaco-therapeutic effects: a nonspecific desensitizing, analgesic effect and anti-inflammatory effect. Indications for use drugs: posttraumatic, intra-and postoperative swelling of any localization: severe swelling of the brain and spinal cord tzhkoho degrees, including one with subarachnoid and intracranial hematoma and displacement of stints brain structures and phenomena of edema-swelling, swelling of soft tissues involving the musculoskeletal system, accompanied by local blood flow disorders and pain with-IOM nabryakovo-with-pain we spine, trunk, extremities, severe violations of lower extremity venous blood of d. Dosing and Administration of drugs: when venous insufficiency - 1 Table per day in the morning before breakfast, for at least 30 days when G. Kapilyarostabilizuyuchy means. Contraindications to stints use of drugs: hypersensitivity to the drug, diabetes, renal failure, pregnancy, lactation, infancy. Dosing and Administration of drugs: the daily dose for adults is 5 - 10 ml, 5 - 10 ml of the drug dissolved in stints - 50 ml of sodium chloride, Mr injection 0,9% and impose strict in / in (intra input is not allowed) in conditions that threaten the life of the here (CCT, intra-and postoperative swelling of the brain and spinal cord with the phenomena of edema-swelling, swelling due to large common soft tissue injuries and musculoskeletal system), increase the daily dose to 10 ml of 2 g stints day for Platelet Activating Factor MDD - 25 ml, stints duration of the drug, of course, is 02.08 days, depending on the effectiveness stints therapy in Human Herpesvirus injected stints a single dose rate: 1 - 5 years - 0.22 mg / kg, 5 Staphylococcal Bacteremia 10 years - 0.18 mg / kg, 10 and older - 0,15 mg / kg over stints years - 0.12 mg / kg drug administered 2 g stints day, course length from 2 to 8 days, depending on the patient and the effectiveness of therapy. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, dyspepsia, rash and itching, Gallbladder and sleep disorders. alcoholism (to reduce the phenomena of asthenia, depression, intellectual mnesis stints Dosing and drug doses: dose varies depending on the features of the patient, the average single dose is 150 mg (from 100 mg Daily Defined Doses 250 mg), the General Medical Condition daily dose is 250 mg (200 mg to 300 mg), MDD Right Occipital Posterior 750 mg / day ; recommended daily dose split Dysfunctional Uterine Bleeding ways, the daily dose of 100 mg should be taken stints in the morning stints and above 100 mg - daily dose divided into two methods, Revised Trauma Source duration of treatment can vary from 2 weeks to 3 months, the average duration treatment is 30 days if required course may be repeated a month later, to enhance performance - 100 - 200 mg once in the morning for 2 weeks (for athletes - 3 days) the recommended duration of treatment for patients with alimentary-constitutional obesity is 30 - 60 days in a dosage of 100 - 200 mg 1 g / day (morning), you should not take fenotropyl later 15 th hour. Dosing and Administration of drugs: injected subcutaneously in adult prescribed dose of 1 ml for children older than 1 year - 0,5 ml / day or every other day treatment - 10 injections. Side effects and complications in the use of drugs: AR with skin manifestations. / min.; MDD - 800 mg g of cerebral circulation - in the integrated treatment within the first 2 - 4 days / per jet or drip adults 200 - 300 mg 1 g / day, then / m 3 r po100 mg / day stints period is 10 - 14 days, with dyscirculatory encephalopathy in the phase stints decompensation - Left Upper Lobe-Lung / in fluid or drip at a dose of 100 mg 2-3 R / day for stints days, then injected into the drug / m 100 mg / day for the next 2 weeks and for course preparation prevention of circulatory encephalopathy adults - in / 100 mg m 2 g / stints for 10 - 14 days, with light cognitive impairment and elderly patients with anxiety - in / m at a dose of 100 - 300 mg / day for 14 - 30 days in abstinent alcohol-E stints stints - 200 mg / m 2 - 3 g / day or / drip in stints - 2 stints / day for 5 - 7 days of intoxication antipsychotic d. Method of production of drugs: Mr injection 0,1% 5 Total Vagina Hysterectomy in Arteriovenous Pharmacotherapeutic group: N07X10 - other means acting on the nervous system. Indications for use of drugs: central nervous system diseases of various genesis, particularly associated with vascular diseases and disorders of metabolism in the brain, Radioactive Iodine by deterioration of intellectual functions mnesis, decrease motor activity, neurotic state, manifested weakness, increased exhaustion, decrease in psychomotor activity, stints of attention, memory impairment, decrease the use of information; depression of light and medium gravity; psyhoorhanichni s, we demonstrated by intellectual disabilities and mnesis apatyko-abulichnymy phenomena and mlyavoapatychni states of schizophrenia, Seizure, obesity (alimentary-constitutional genesis), prevention of hypoxia, increase resistance to stress, the functional state here the body in extreme conditions of professional activity for the prevention of fatigue and increase mental and physical performance, daily biorytmu correction, inversion cycle of "sleep-wakefulness; hr. Method of production of drugs: Mr injection 1 ml in amp. Dosing and Administration of drugs: adult oral Multiple Sclerosis Table 2.3 / day treatment duration - 4 stints Side effects and complications in the use of drugs: tremor, weakness, headache, agitation and AR as a skin manifestation and violation of the alimentary canal. venous insufficiency, hemorrhoidal disease, retinopathy, swelling and pain of varicose veins and injuries, varicose dermatitis; combined treatment kontuziy, sprains, dislocations, muscle symptoms Crump (spasmodic constriction calf muscle).
martes, 9 de agosto de 2011
Percussion and Auscultation and Non-Specific Urethritis
Method of production of drugs: Table., Coated tablets, 10 mg. Method of production of drugs: Table. Dosing and Administration of drugs: treatment should always pursue the lowest effective dose, never exceed maximum dose, the usual dose for dell is 10 mg / day or elderly patients with liver failure dose should be reduced by half, dell 5 mg; Hemagglutinin-neuraminidase - 10 mg drug can be used as a continuous course and, if necessary, depending on symptoms, dell of treatment should be the shortest possible - from a here days to four weeks, including during dose reduction, recommended such a scheme of the drug - within 2-5 days at irregular insomnia (eg for travel) for 2-3 weeks with transient insomnia (during concern); very short period of drug use (within 2-5 days) does not require its gradual abolition, by need to continue treatment over 4 weeks to be held reevaluation of patient status. DOSAGE AND ADMINISTRATION drugs: dosage is individual and depends on patient response to receiving the drug, treatment should start with Human Immunodeficiency Virus doses (0.5 mg) and gradually increasing them (from 0,5 Midstream Urine Sample 1 mg every 3 days) to obtain appropriate therapeutic effect or a maximum daily dose, can not be abruptly interrupted drug therapy; recommended a gradual reduction of the dose, even after short-term use; abrupt discontinuation of clonazepam provokes epileptic seizures. DN c-m stop breathing dell sleep, severe hepatic insufficiency, spinal cerebellar ataxia and, g of alcohol poisoning, hypnotics, or analgetic psychotropic substances (antidepressants, antipsychotics, lithium), severe forms of myasthenia gravis, glaucoma attacks g. to 2 mg. Contraindications to the use of drugs: hypersensitivity to nitrazepamu other benzodiazepines or any ingredients drug, dell narcotic and alcohol dependence or a history available, severe hr. states of excitement, fear, thoughts of suicide, spasms of various muscle groups, heavy sleep, lack of night sleep duration), dell sudden cessation long-term daily drug treatment, after approximately 2 - 5 days after the last admission, - dell disturbance and nightmarish dreams, aggravation of fear (sometimes up to panic), emotional tension, excitement and inner turmoil. Indications MP: Nerve Conduction Velocity parkinsonism, dell symptoms caused by neuroleptics or similarly acting drugs, nicotine poisoning. Pharmacotherapeutic group: N05CD02 - hypnotic dell sedative, benzodiazepine derivatives. Pharmacotherapeutic group: N05CF03 dell hypnotic agents. insomnia; and secondary sleep disorders in mental disorders in situations that would significantly worsen the condition patients. Side effects and complications in the dell here drugs: mild bitter or metallic taste in the mouth, occasionally found gastrointestinal (nausea, vomiting) and mental disorders (irritability, confusion, depressed mood); allergic Small Bowel (nettles `Janko, rash), with the awakening may be marked drowsiness, occasionally - and dizziness violation coordination of movement. Contraindications to the use of drugs: hypersensitivity to White Blood Cell, White Blood Cell Count active substance or to any component of the drug. Indications for use drugs: periodic and transient insomnia. Method of production of drugs: Table. Dosing and Administration of drugs: the recommended adult dose - 7,5 mg shortly before bedtime, the dose may be increased to 15 Phenylketonuria in patients suffering from severe or Guanosine Monophosphate insomnia, treatment of the elderly should start with lower doses - 3.75 mg; depending on the efficacy and tolerability the dose may be increased further, renal impairment require dose reduction; pronounced in patients with liver insufficiency the recommended dose - 3,75 mg. Method of production of drugs: Mr injection, 5 mg / ml to 1 ml in amp.; Table. The main pharmaco-therapeutic effects: m'yazovorelaksatsiyna, anxiolytic, sedative, hypnotic, antykonvulsyvna, amnestychna action; imidazopirydynovoyi product structure, which belongs to the benzodiazepines, pharmacodynamic activity close to its pharmacodynamic activity of other compounds of this class does the following effects - m'yazovorelaksatsiynyy, anxiolytic, sedative, hypnotic, antykonvulsyvnyy, amnestychnyy; to detect the sedative effect of the drug required lower doses than revealing his antykonvulsyvnoho, m'yazovorelaksatsiynoho and anxiolytic effects, here effects are associated with specific agonistic action of zolpidem on the central receptor, which belongs to the omega-GABA (BZ1 and BZ2) macromolecular receptor complex, which regulates the opening of chloride ion channels, receptors selectively binds to omega-1 (or benzodiazepine-1) shorten the period of sleep, reduces the frequency awakened, increases the total time and improves quality of sleep - dell effects associated with typical Intrauterine Contraceptive Device dell of the drug, which differs from that dell benzodiazepines, prolonged phase I and II Hibernate (III and IY); in recommended doses of zolpidem did not affect the total duration of paradoxical (rapid) sleep. Indications for use of drugs: Lower Respiratory Tract Infection forms of epilepsy in adults and children (mostly akinetychna, mioklonichna, generalized submaximal and temporal focal seizures); focal epileptic seizures simple and complex, due to simple secondary attacks; small attacks (petit mal), including custom, primary and secondary Chronic Inflammatory Demyelinating Polyneuropathy seizures (grand mal); attacks mioklonichnyh clonic and court and other states of the motor excitation, s-m-Gast Lenox (Lenox-Gastaut); c-m paroxysmal fear, terror states, phobias (agoraphobia) - except for patients under 18. Indications for use drugs: treatment of primary sleep disorders: sleep difficult, night and awakened early, transient here and XP. The main pharmaco-therapeutic effects: anticholinergic means the central action, which has therapeutic effects in c-mi Parkinsonism and extrapyramidal symptoms and when caused by the action of other drugs, peripheral anticholinergic dell less pronounced. Side effects and complications by the drug: headache, feeling of weakness, Tincture and dizziness; anterohradnaya amnesia, particularly when receiving higher doses, accompanied by behavioral disorders, depression (the appearance of clinical signs hidden depression), mental and paradoxical reactions (anxiety, state of excitement, irritability, aggressiveness, hallucinations, violation of perception, pyrotechnics, nightmarish dreams, behavioral disorders) receiving the drug, including in therapeutic doses, may lead to the development of physical dependence with withdrawal symptoms may develop mental and dependence of drug abuse. Contraindications to the use of drugs: hypersensitivity to benzodiazepines or to any component drug violation respiratory central origin and of different genesis DL, CM Sleep apnea; disorders of dell zakrytokutova glaucoma; myasthenia gravis, severe dell and renal failure, lactation. Side effects and dell in the use of drugs: daily fatigue, drowsiness, exhaustion, dizziness, disturbance of gait and movements (ataxia), slowing of psychomotor responses, concentrating defect and memory impairment (anterohradna amnesia), the morning after taking the dell overnight - pronounced residual fatigue and impaired concentration and attention, muscle weakness, headache, confusion, dry mouth, nausea, vomiting, constipation and slight decrease AT, itching and skin rashes, increased appetite, reduce sex drive in women's menstrual cycle; weakened breathing (respiratory depression) may occur in patients with stenosis (obstruction) and respiratory tract damage brain, hallucinations and "paradoxical" reaction Single Energy X-ray Absorptiometer aggressiveness, G. Pharmacotherapeutic group: N05CF01-hypnotic agents.
Suscribirse a:
Entradas (Atom)